← Back to Search
Genes That Mediate Breast Cancer Metastasis To Lung
A. Minn, G. Gupta, P. Siegel, P. Bos, Weiping Shu, D. Giri, A. Viale, A. Olshen, W. Gerald, J. Massagué
Published 2005 · Medicine, Biology
Download PDFAnalyze on Scholarcy
By means of in vivo selection, transcriptomic analysis, functional verification and clinical validation, here we identify a set of genes that marks and mediates breast cancer metastasis to the lungs. Some of these genes serve dual functions, providing growth advantages both in the primary tumour and in the lung microenvironment. Others contribute to aggressive growth selectively in the lung. Many encode extracellular proteins and are of previously unknown relevance to cancer metastasis.
This paper references
SPARC and tumor growth: Where the seed meets the soil?
P. E. Framson (2004)
Molecular portraits of human breast tumours
C. Perou (2000)
A molecular signature of metastasis in primary solid tumors
S. Ramaswamy (2003)
Helix-Loop-Helix Proteins in Mammary Gland Development and Breast Cancer
P. Desprez (2004)
Tumor progression and metastasis
R. Kath (1990)
Enhanced Interleukin (IL)-13 Responses in Mice Lacking IL-13 Receptor α 2
N. Wood (2003)
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.
A. Minn (2005)
The role of COX-2 inhibition in breast cancer treatment and prevention.
B. Arun (2004)
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
J. Yang (2004)
Untangling the ErbB signalling network
Y. Yarden (2001)
Metalloproteinases: role in breast carcinogenesis, invasion and metastasis
M. Duffy (2000)
Gene-expression profiles predict survival of patients with lung adenocarcinoma
D. Beer (2002)
Genomic analysis of metastasis reveals an essential role for RhoC
E. Clark (2000)
Metastasis: Dissemination and growth of cancer cells in metastatic sites
A. Chambers (2002)
The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited
I. Fidler (2003)
Cancer and the chemokine network
F. Balkwill (2004)
A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging
V. Ponomarev (2003)
Altered Expression of Metastasis-Associated and Regulatory Molecules in Effusions from Breast Cancer Patients
B. Davidson (2004)
Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterization
R. Cailleau (2007)
Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data
R. Simon (2003)
Epiregulin Is a Potent Pan-ErbB Ligand That Preferentially Activates Heterodimeric Receptor Complexes*
M. Shelly (1998)
Gene expression profiling predicts clinical outcome of breast cancer
L. J. Veer (2002)
Clinical progression of breast cancer malignant behavior: what to expect and when to expect it.
R. Heimann (2000)
A progression puzzle.
R. Bernards (2002)
Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis
E. Solomayer (2004)
Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumour progression
B Davidson (2004)
New functions for the matrix metalloproteinases in cancer progression
M. Egeblad (2002)
Metastatic Potential Generic Predisposition of the Primary Tumor or Rare, Metastatic Variants—Or Both?
R. Hynes (2003)
Probabilities of death from breast cancer and other causes among female breast cancer patients.
C. Schairer (2004)
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma.
D. O'hanlon (2002)
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
S. Amatschek (2004)
Gene expression profiling predicts clinical outcome of breast cancer
van ’t Veer (2002)
A multigenic program mediating breast cancer metastasis to bone.
Y. Kang (2003)
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
Id proteins in development, cell cycle and cancer.
M. Ruzinova (2003)
This paper is referenced by
Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis
E. Louie (2013)
The novel metastasis promoter Merm1/Wbscr22 enhances tumor cell survival in the vasculature by suppressing Zac1/p53-dependent apoptosis.
Y. Nakazawa (2011)
Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling data
Huixia Wang (2006)
Expression of angiopoietin‐like protein 4 at the fracture site: Regulation by hypoxia and osteoblastic differentiation
Sabrina S Wilson (2015)
The metastatic microenvironment: Brain‐residing melanoma metastasis and dormant micrometastasis
Sivan Izraely (2012)
Hybrid Method for Prediction of Metastasis in Breast Cancer Patients Using Gene Expression Signals
A. Dehnavi (2013)
Tracing the origins of metastasis
D. Nguyen (2011)
Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis
R. Cao (2014)
Establishment and characterization of highly osteolytic luminal breast cancer cell lines by intracaudal arterial injection
Y. Han (2019)
Cancer Stem Cells: The Role of the Environment and Methods to Identify Them
G. Pirozzi (2011)
Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
Meital Ben-David-Naim (2019)
Pathology and Biological Markers of Invasive Breast Cancer
Rodrigo Gonçalves (2014)
Osteoactivin Promotes Breast Cancer Metastasis to Bone April
A. N. Rose (2007)
[Screening and establishment of human lung cancer cell lines with organ-specific metastasis potential].
Q. Zhou (2014)
Molecular imaging strategies for drug discovery and development.
S. Gross (2006)
Role of KCNMA1 gene in breast cancer invasion and metastasis to brain
D. Khaitan (2008)
Exploring the molecular basis of tumor metastasis by microarray analysis.
J. Yang (2006)
Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle
M. K. Singh (2007)
Investigating the contribution of FGF receptors in breast tumorigenesis using models of mammary cancer
J. Dey (2010)
Gene Expression Arrays in Pancreatic Cancer Drug Discovery Research
Charles Gawad (2010)
Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.
J. Staaf (2010)
A specific peptide ligand-modified lipid nanoparticle carrier for the inhibition of tumor metastasis growth.
Z. Wang (2013)
PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.
Nils Halberg (2016)
Human epidermal growth factor receptor-2-positive breast cancer : does estrogen receptor status de fi ne two distinct subtypes ?
M. Carayol (2013)
Bioengineered implantable scaffolds as a tool to study stromal-derived factors in metastatic cancer models.
Francesca Bersani (2014)
Microbial and epigenetic factors in the pathogenesis of nasopharyngeal carcinoma
Xiaoying Zhou (2015)
Integrated gene expression profile predicts prognosis of breast cancer patients
Lian-fang Li (2008)
The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Bérengère Fayard (2009)
Sialic Acid Metabolism: A Key Player in Breast Cancer Metastasis Revealed by Metabolomics
S. T. Teoh (2018)
Human breast cancer cells educate macrophages toward the M2 activation status
S. Sousa (2015)
Long non-coding RNAs as prognostic markers in human breast cancer
Hairong Liu (2016)
Award Number: W81XWH-06-1-0073 TITLE: Do Deregulated Cas Proteins Induce Genomic Instability in Early-Stage Ovarian Cancer
Erica A. Golemis (2006)See more